Amgen has appointed Wanda Austin to its board of directors and as a member of its audit committee and corporate responsibility and compliance committee.
Austin most recently retired from her role as president and chief executive officer of space programme The Aerospace Corporation, where she has served from 2008 to 2016.
Robert Bradway, chairman and chief executive officer, Amgen, said: “We are pleased to welcome Dr Wanda Austin to Amgen’s board.
“Wanda’s deep experience in long-cycle technology and engineering settings and her senior leadership experience will be invaluable to Amgen.”
The addition of Austin will see Amgen’s board comprise of 14 directors, 13 of whom are independent of the company.